The project, identified as Rebel Medicine Inc. (despite the confusing 'SwiftKeeper' alias in the submission), is a legitimate Series A biotechnology company ($6M+ funding) developing Alevatrix™, a high-utility non-opioid pain management solution. While the company demonstrates strong clinical traction (IND clearance, Phase 2 readiness) and significant technical innovation, the submission quality was exceptionally poor—containing false claims ('most people have used my product') and generic data. The final score reflects the high intrinsic value of the venture-backed company, heavily penalized for the inaccurate and low-effort submission details.
Ready to Compete for $150k+ in Prizes?
Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes
Score Breakdown
Project Details
Algorithm Insights
Recommendations to Increase Usefulness Score
Document User Growth
Provide specific metrics on user acquisition and retention rates
Showcase Revenue Model
Detail sustainable monetization strategy and current revenue streams
Expand Evidence Base
Include testimonials, case studies, and third-party validation
Technical Roadmap
Share development milestones and feature completion timeline